To the Editor: Primary cicatricial (scarring) alopecias are disorders in which the follicular unit is targeted by inflammation and replaced by fibrosis, leading to permanent hair loss. They are categorized according to the inflammatory cell present. 1 Lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are lymphocytic scarring alopecias that differ clinically, but have identical histologic findings. 2 After observing deep perifollicular inflammation in several biopsy specimens of FFA, the authors sought to study the depth of inflammation in LPP and FFA.
After obtaining approval from the Boston University Institutional Review Board, a retrospective review of scalp biopsy specimens coded as LPP and FFA from January 1, 2013, through December 31, 2014, was completed. All but 1 biopsy specimen had been embedded and cut in a horizontal fashion as described by Headington. 3 The degree of inflammation was categorized as either mild or moderate/ heavy, determined by the width of the infiltrate in comparison with the width of the outer root sheath; mild was less than the thickness of the outer root sheath, and moderate/heavy was equal to or thicker. The maximum depth of inflammation, maximum depth of fibrosis, and level of maximum inflammation were categorized into 4 different groups. Z-score tests were used for comparison.
In all, 32 cases of LPP from 30 patients and 37 cases of FFA from 36 patients were studied. Patients were mostly women aged 26 to 80 years (mean age 52 years for LPP and 60 years for FFA). Moderate/ heavy inflammation was found in the majority of patients with both LPP and FFA (78% and 76%, respectively, P ¼ .81). In these patients, although most exhibited the maximum degree of inflammation at the isthmus (76% for LPP and 79% for FFA), a significant number of patients with FFA had inflammation extending below the isthmus in comparison with LPP (92% vs 63%, P ¼ .002) (Fig 1) . In addition, 96% of patients with FFA had fibrosis extending below the isthmus, most (88.4%) to the dermal/subcutaneous junction or below (P ¼ .33) (Fig 2) .
There is only a single study that compares the histopathology of LPP and FFA. 4 Variable amounts of perifollicular inflammation at the isthmus and infundibulum were found, the latter heavier in LPP than FFA, and more apoptotic follicular keratinocytes were noted in FFA. We found that both LPP and FFA typically exhibit moderate to heavy inflammation and perifollicular fibrosis, often extending below the isthmus.
One limitation of this study is that there was no attempt to correlate histopathologic findings with duration of disease or effects of prior treatment, factors that are difficult to pinpoint retrospectively. Why inflammation extends deeper in FFA is not known; perhaps it is the proximity to facial skin. The finding of deep perifollicular inflammation in FFA and LPP is important, not only because it might help distinguish between FFA and LPP in instances where clinical information is lacking, but because awareness could help avoid confusion with chronic cutaneous (discoid) lupus erythematosus. 5 The finding of deep perifollicular inflammation in the reticular dermis and even the subcutaneous tissue should not discourage dermatopathologists from making a diagnosis of LPP and especially FFA. 
Hypopigmentation in frontal fibrosing alopecia
To the Editor: Frontal fibrosing alopecia (FFA), a variant of lichen planopilaris (LPP), is a progressive scarring process that clinically presents as symmetrical frontoparietal hair loss. 1 Skin in the affected areas is thin, hypopigmented, and with increased vascular prominence. 2 This partial or complete loss of pigmentation can be appreciated on examination with a Wood's lamp to explore the nature of the observed hypopigmentation (Fig 1) .
Melanocyte counts and epidermal thickness were compared in scalp biopsy specimens obtained from patients with FFA, LPP, and controls. Histologic scalp specimens from patients with scarring alopecias (FFA, n ¼ 5; LPP, n ¼ 4) and controls (n ¼ 10) were evaluated for epidermal melanocyte counts using Melan-A and tyrosinase immunohistochemical stains. The melanocyte count was evaluated by 2 independent dermatopathologists (MV, NAM) blinded to the diagnoses. Melanocytes were counted in 3 consecutive high-power fields (HPFs). Two-tailed unpaired t tests with an alpha of 0.05 were used during the analysis of data.
The FFA melanocyte counts were found to be lower than the counts seen in biopsy specimens obtained from patients with LPP and controls. The mean epidermal melanocyte counts in FFA scalps were 2.7 6 1.3 ( per HPF) with Melan-A stain and 1.5 6 0.7 ( per HPF) with tyrosinase stain (Fig 2) . Control group means were 7.9 6 3.5 and 4.9 6 3.7, respectively; in the LPP group, means were 7.3 6 2.7 and 4.6 6 2.8. Melan-A staining revealed statistically significant differences between FFA and LPP (P ¼ .012) and between the FFA and control groups (P ¼ .006). There was also a significant difference between the FFA and LPP groups with tyrosinase stain (P ¼ .043). To explore epidermal thickness in patients with LPP and FFA, histologic measurements 
